We are live on ! Find out more
TAM

TFG Asset Management Portfolio holdings

AUM $515M
1-Year Est. Return 24.47%
This Fund
S&P 500
This Quarter Est. Return
+24.94%
1 Year Est. Return
+24.47%
3 Year Est. Return
+54.92%
5 Year Est. Return
+65.34%
10 Year Est. Return
+105.07%
AUM
$474M
AUM Growth
-$273M
Cap. Flow
-$57.4M
Cap. Flow %
-12.1%
Top 10 Hldgs %
86.79%
Holding
46
New
9
Increased
7
Reduced
6
Closed
18

Top Buys

Rank Stock Value
1
PATH icon
UiPath
PATH
+$7.78M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$5.68M
3
PRAX icon
Praxis Precision Medicines
PRAX
+$4.27M
4
RAPT
RAPT Therapeutics
RAPT
+$4.09M
5
NKTR icon
Nektar Therapeutics
NKTR
+$3.88M

Top Sells

Rank Stock Value
1
TARS icon
Tarsus Pharmaceuticals
TARS
+$7.43M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$5.92M
3
SRRK icon
Scholar Rock
SRRK
+$4.39M
4
TECX
Tectonic Therapeutic
TECX
+$3.82M
5
AXSM icon
Axsome Therapeutics
AXSM
+$2.73M

Sector Composition

Rank Sector Weight
1 Technology 71.19%
2 Healthcare 23.07%
3 Energy 5.75%
4 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNOW icon
26
Snowflake
SNOW
$102B
$2.19M 0.46%
10,000
– –
ZVRA icon
27
Zevra Therapeutics
ZVRA
$562M
$1.72M 0.36%
+192,518
New +$1.82M
AVDL
28
DELISTED
Avadel Pharmaceuticals
AVDL
$943K 0.2%
+43,763
New +$850K
ABVX
29
Abivax
ABVX
$10.9B
– –
-30,000
Closed -$2.55M
ACAD icon
30
Acadia Pharmaceuticals
ACAD
$4.43B
– –
-86,071
Closed -$1.84M
CCJ icon
31
Cameco
CCJ
$37.6B
– –
-16,015
Closed -$1.34M
DSX.WS icon
32
Diana Shipping Inc Warrants exp 2026
DSX.WS
$5.75M
– –
-233,400
Closed -$22.8K
HBM icon
33
Hudbay
HBM
$10.1B
– –
-117,500
Closed -$1.78M
HYG icon
34
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
– –
-72,961
Closed -$5.92M
HYG icon
35
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
– –
-726,900
Closed -$59M
KROS icon
36
Keros Therapeutics
KROS
$199M
– –
-43,000
Closed -$680K
NXE icon
37
NexGen Energy
NXE
$6.06B
– –
-42,000
Closed -$376K
RARE icon
38
Ultragenyx Pharmaceutical
RARE
$2.45B
– –
-17,718
Closed -$533K
RLAY icon
39
Relay Therapeutics
RLAY
$4.1B
– –
-223,123
Closed -$1.16M
SONDW
40
DELISTED
Sonder Holdings Inc Warrants
SONDW
– –
-18,898
Closed -$204
SRRK icon
41
Scholar Rock
SRRK
$5.67B
– –
-117,882
Closed -$4.39M
TARS icon
42
Tarsus Pharmaceuticals
TARS
$2.58B
– –
-125,000
Closed -$7.43M
TECK icon
43
Teck Resources
TECK
$29.6B
– –
-18,068
Closed -$793K
TECX
44
Tectonic Therapeutic
TECX
$529M
– –
-243,728
Closed -$3.82M
LAR
45
Lithium Argentina AG
LAR
$985M
– –
-200,000
Closed -$668K
WBI
46
WaterBridge Infrastructure LLC
WBI
$1.61B
– –
-20,000
Closed -$504K
1
2

Similar funds

VPP
Vertex Planning Partners Downers Grove, Illinois $515M AUM 14.66% 1-Year Est. Return
WAM
Winslow Asset Management Beachwood, Ohio $515M AUM 30.41% 1-Year Est. Return
PDIP
Palo Duro Investment Partners Chicago, Illinois $515M AUM 36.69% 1-Year Est. Return
AGC
Aspen Grove Capital Avon, Colorado $514M AUM 21.8% 1-Year Est. Return
SC
Schoolcraft Capital Boulder, Colorado $516M AUM 16.37% 1-Year Est. Return
HW
Hamilton Wealth Encino, California $513M AUM 33.8% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return
AAM
AR Asset Management West Hollywood, California $517M AUM 18.31% 1-Year Est. Return

TFG Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, TFG Asset Management held 46 positions worth $474M, down 37% from $748M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

TFG Asset Management withdrew a net $57.4M in Q4 2025, closing 18 positions and reducing 6 holdings. Its most notable exit was Tarsus Pharmaceuticals, an estimated $7.43M position sold in full.

By sector, the portfolio is most concentrated in Technology at 71% of assets, up from 38% a quarter earlier, followed by Healthcare and Energy.

Against the trend, TFG Asset Management opened a new position in Agios Pharmaceuticals worth $4.41M.

  • TFG Asset Management's largest Q4 2025 buy was Agios Pharmaceuticals: 162,018 shares worth $4.41M.
  • TFG Asset Management added most to UiPath in Q4 2025, an estimated $7.78M increase.
  • TFG Asset Management's biggest Q4 2025 reduction was Axsome Therapeutics, cutting an estimated $2.73M.
  • TFG Asset Management fully exited Tarsus Pharmaceuticals in Q4 2025, selling an estimated $7.43M.
  • TFG Asset Management's ten largest holdings make up 87% of its $474M portfolio in Q4 2025.
  • TFG Asset Management opened 9 new positions and closed 18 in Q4 2025.
  • TFG Asset Management's portfolio value fell 37% quarter-over-quarter to $474M.

Based on TFG Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.